Oiltek, Inc.Convertible Notes Amendment • April 3rd, 2009 • Oiltek, Inc. • Oil & gas field machinery & equipment
Reference is made to the Convertible Notes (the “Notes”) dated November 28, 2006 between Michael L. Ray (the”Payee") and Oiltek, Inc. (the "Payor") in the aggregate amount of $7,500. This will confirm our agreement to amend the terms and conditions of the Notes as follows:
Oiltek, Inc.Convertible Notes Amendment • April 3rd, 2009 • Oiltek, Inc. • Oil & gas field machinery & equipment
Reference is made to the Convertible Notes (the “Notes”) dated November 28, 2006 between Michael L. Ray (the “Payee”) and Oiltek, Inc. (the “Payor”) in the aggregate amount of $7,500. This will confirm our agreement to amend the terms and conditions of the Notes as follows:
AMENDMENT TO CONVERTIBLE NOTESConvertible Notes Amendment • January 4th, 2011 • Quantum Fuel Systems Technologies Worldwide, Inc. • Motor vehicle parts & accessories
This Amendment to the Convertible Notes (as defined below) is made and entered into as of January 3, 2011 by Quantum Fuel Systems Technologies Worldwide, Inc., a Delaware corporation (the "Company"), and WB QT, LLC, a Delaware limited liability company (the "Purchaser"). The Company is indebted to the Purchaser under the following convertible promissory notes (the "Convertible Notes"):
AMENDMENT TO CONVERTIBLE NOTESConvertible Notes Amendment • January 5th, 2012 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • New York
This AMENDMENT TO CONVERTIBLE NOTES (this “Amendment”) is made and entered into as of December 31, 2011 by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and Euro Pacific Capital, Inc. (the “Investor Representative”).
Oiltek, Inc.Convertible Notes Amendment • April 3rd, 2009 • Oiltek, Inc. • Oil & gas field machinery & equipment
Reference is made to the Convertible Notes (the “Notes”) dated various dates between Avalon Oil & Gas (the “Payee”) and Oiltek, Inc. (the “Payor”) in the aggregate amount of $77,400. This will confirm our agreement to amend the terms and conditions of the Notes as follows:
Amendment to Convertible NotesConvertible Notes Amendment • May 8th, 2019 • Aethlon Medical Inc • Laboratory analytical instruments • New York
This Amendment to Convertible Notes (this “Agreement”), effective as of May 6, 2019 (the “Effective Date”), is made by and among Aethlon Medical, Inc., a Nevada corporation (the “Company”), and the undersigned holders (collectively, the “Note Holders”) of outstanding Convertible Notes issued by the Company on November 6, 2014 and December 30, 2016, as amended to date, as detailed on Exhibit A attached hereto (the “Notes”); and
AMENDMENT TO CONVERTIBLE NOTESConvertible Notes Amendment • January 5th, 2018 • Cel Sci Corp • Biological products, (no disgnostic substances)
AGREEMENT TO AMEND THE CONVERTIBLE NOTESConvertible Notes Amendment • April 18th, 2000 • Blue Rhino Corp • Retail-retail stores, nec
THIRD AMENDMENT TO CONVERTIBLE NOTESConvertible Notes Amendment • June 28th, 2012 • Bohai Pharmaceuticals Group, Inc. • Pharmaceutical preparations • New York
This THIRD AMENDMENT TO CONVERTIBLE NOTES (this “Amendment”) is made and entered into as of June 27, 2012 by and between Bohai Pharmaceuticals Group, Inc., a Nevada corporation (the “Company”), and Euro Pacific Capital, Inc. (the “Investor Representative”).
